GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LabGenomics Co Ltd (XKRX:084650) » Definitions » Cyclically Adjusted PS Ratio

LabGenomics Co (XKRX:084650) Cyclically Adjusted PS Ratio : 1.75 (As of Jun. 05, 2025)


View and export this data going back to 2013. Start your Free Trial

What is LabGenomics Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), LabGenomics Co's current share price is ₩2675.00. LabGenomics Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩1,532.03. LabGenomics Co's Cyclically Adjusted PS Ratio for today is 1.75.

The historical rank and industry rank for LabGenomics Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:084650' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.37   Med: 2.1   Max: 4.14
Current: 1.8

During the past years, LabGenomics Co's highest Cyclically Adjusted PS Ratio was 4.14. The lowest was 1.37. And the median was 2.10.

XKRX:084650's Cyclically Adjusted PS Ratio is ranked better than
56.06% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.09 vs XKRX:084650: 1.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LabGenomics Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩293.336. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩1,532.03 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


LabGenomics Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for LabGenomics Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabGenomics Co Cyclically Adjusted PS Ratio Chart

LabGenomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.72 1.66

LabGenomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 1.50 2.25 1.66 1.39

Competitive Comparison of LabGenomics Co's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, LabGenomics Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LabGenomics Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LabGenomics Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LabGenomics Co's Cyclically Adjusted PS Ratio falls into.


;
;

LabGenomics Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LabGenomics Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2675.00/1532.03
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabGenomics Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, LabGenomics Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=293.336/122.5900*122.5900
=293.336

Current CPI (Mar. 2025) = 122.5900.

LabGenomics Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 109.843 100.051 134.588
201509 114.496 100.111 140.205
201512 133.533 100.220 163.338
201603 117.134 100.561 142.794
201606 123.966 100.791 150.778
201609 114.751 101.461 138.647
201612 122.907 101.561 148.355
201703 103.427 102.851 123.277
201706 118.521 102.611 141.597
201709 174.197 103.491 206.346
201712 136.157 102.991 162.068
201803 118.725 104.101 139.812
201806 122.294 104.130 143.974
201809 126.111 105.651 146.331
201812 157.065 104.351 184.518
201903 122.766 104.491 144.031
201906 138.810 104.881 162.248
201909 130.186 105.200 151.706
201912 155.463 105.121 181.297
202003 188.345 105.354 219.158
202006 726.063 105.112 846.794
202009 394.864 106.198 455.814
202012 467.216 105.765 541.538
202103 501.295 107.357 572.423
202106 264.475 107.579 301.380
202109 798.585 108.759 900.140
202112 914.910 109.676 1,022.634
202203 3,569.154 111.848 3,911.939
202206 321.264 114.072 345.253
202209 361.145 114.715 385.936
202212 275.646 115.179 293.381
202303 187.001 116.507 196.764
202306 206.332 117.182 215.854
202309 287.251 118.964 296.007
202312 427.880 118.837 441.393
202403 270.604 120.123 276.161
202406 294.810 120.007 301.155
202409 287.705 120.861 291.820
202412 301.906 121.135 305.532
202503 293.336 122.590 293.336

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LabGenomics Co  (XKRX:084650) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LabGenomics Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of LabGenomics Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LabGenomics Co Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, 6F-B, Bundang-gu, Korea Bio Park Building, Gyeonggi-do, Seongnam, KOR, 463-400
LabGenomics Co Ltd is a healthcare company. The Company operates in three business divisions namely NGS, Diagnostic service, IVD products. NGS offers mom guard, cancer panel, Predisposition panel and PGS; Diagnostic service provides esoteric tests such as cancer genetics, genetic disorder. Whereas IVD products include DNA chips, PCR kit among others.

LabGenomics Co Headlines

No Headlines